Genotech Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011
Operating Revenue	7,281	6,449	6,286	6,935	6,539
Other Revenue	-0	-	-	0	0
Revenue	7,281	6,449	6,286	6,935	6,539
Revenue Growth (YoY)	12.91%	2.59%	-9.36%	6.05%	-5.51%
Cost of Revenue	6,319	5,205	5,881	4,855	4,416
Gross Profit	962.09	1,243	405.12	2,080	2,123
Selling, General & Admin	1,359	1,121	1,188	1,190	1,172
Research & Development	396.43	65.36	243.46	232.18	179.02
Amortization of Goodwill & Intangibles	26.63	31.4	-	-	-
Other Operating Expenses	110.27	99.78	93.43	93.01	87.89
Operating Expenses	1,974	1,240	1,575	1,526	1,460
Operating Income	-1,012	3.22	-1,170	554.41	662.88
Interest Expense	-382.76	-428.91	-269.43	-313.43	-384.34
Interest & Investment Income	7.48	7.95	10.17	25.08	6.01
Currency Exchange Gain (Loss)	72.7	24.67	21.59	2.8	-
Other Non Operating Income (Expenses)	12.19	1.88	11.75	7.09	179.88
EBT Excluding Unusual Items	-1,303	-391.18	-1,395	275.96	464.43
Asset Writedown	-18.63	-	-830.8	-	-65.2
Other Unusual Items	-	14.4	-	131.33	-
Pretax Income	-1,321	-376.78	-2,226	407.28	399.23
Net Income	-1,321	-376.78	-2,226	407.28	399.23
Net Income to Common	-1,321	-376.78	-2,226	407.28	399.23
Net Income Growth	-	-	-	2.02%	41.32%
Shares Outstanding (Basic)	5	5	4	4	4
Shares Outstanding (Diluted)	5	5	4	4	4
Shares Change (YoY)	2.69%	7.53%	-0.33%	-0.13%	0.29%
EPS (Basic)	-280.00	-82.00	-521.00	95.00	93.00
EPS (Diluted)	-280.00	-82.00	-521.00	95.00	93.00
EPS Growth	-	-	-	2.15%	40.91%
Free Cash Flow	125.36	883.68	-1,026	609.39	-34.6
Free Cash Flow Per Share	26.57	192.32	-240.21	142.14	-8.06
Gross Margin	13.21%	19.28%	6.44%	30.00%	32.47%
Operating Margin	-13.90%	0.05%	-18.61%	7.99%	10.14%
Profit Margin	-18.14%	-5.84%	-35.42%	5.87%	6.11%
Free Cash Flow Margin	1.72%	13.70%	-16.33%	8.79%	-0.53%
EBITDA	-347.19	1,151	-336.89	1,854	2,181
EBITDA Margin	-4.77%	17.84%	-5.36%	26.73%	33.35%
D&A For EBITDA	664.99	1,148	832.7	1,299	1,518
EBIT	-1,012	3.22	-1,170	554.41	662.88
EBIT Margin	-13.90%	0.05%	-18.61%	7.99%	10.14%
Advertising Expenses	12.5	11.2	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.